Oncology Videos
-
Updates from ASCO 2026: Does MRD testing present a molecular window of opportunity for pancreatic cancer?
John Strickler, MD; Ryne Ramaker, MD, PhD
-
Approach to Management of ROS1m NSCLC
Charu Aggarwal, MD, MPH
-
Integrating NORTHSTAR/COMPEL Into Clinical Practice: A Tumor Board Focused on Duration of Osimertinib Therapy
Zofia Piotrowska, MD, MHS; Charu Aggarwal, MD, MPH
-
Colorectal cancer updates from ASCO 2026: Impact of ctDNA and MRD testing on guiding adjuvant chemotherapy and treatment response monitoring
John Strickler, MD; Tanios S. Bekaii-Saab, MD
-
Post ASCO Update on Management of HER2+ Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
Tanios S. Bekaii-Saab, MD
-
Importance of NGS testing for STK11 and KEAP1 mutation and impact on treatment selection
Charu Aggarwal, MD, MPH; Biagio Ricciuti, MD, PhD
-
Advancements in the Treatment of Early Stage Gastroesophageal Adenocarcinoma
Tanios S. Bekaii-Saab, MD
